NanoString Technologies Inc (NASDAQ:NSTG) Director Kirk Malloy sold 1,000 shares of the business’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $25.05, for a total value of $25,050.00. Following the sale, the director now directly owns 1,000 shares of the company’s stock, valued at approximately $25,050. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
NASDAQ:NSTG traded up $0.19 during mid-day trading on Thursday, hitting $26.71. 7,580 shares of the company traded hands, compared to its average volume of 607,091. The company has a market cap of $886.10 million, a price-to-earnings ratio of -9.61 and a beta of 1.08. The company has a debt-to-equity ratio of 1.27, a quick ratio of 4.76 and a current ratio of 5.21. The company has a fifty day moving average of $29.20. NanoString Technologies Inc has a one year low of $13.26 and a one year high of $34.78.
NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings data on Wednesday, July 31st. The biotechnology company reported ($0.57) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.02). The business had revenue of $30.35 million during the quarter, compared to the consensus estimate of $29.00 million. NanoString Technologies had a negative return on equity of 118.03% and a negative net margin of 68.16%. As a group, equities research analysts expect that NanoString Technologies Inc will post -2.35 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Nuveen Asset Management LLC bought a new position in shares of NanoString Technologies in the second quarter worth about $18,453,000. UBS Asset Management Americas Inc. bought a new position in NanoString Technologies during the second quarter valued at approximately $612,000. Jane Street Group LLC bought a new position in NanoString Technologies during the second quarter valued at approximately $363,000. Citadel Advisors LLC boosted its stake in NanoString Technologies by 137.3% during the second quarter. Citadel Advisors LLC now owns 196,006 shares of the biotechnology company’s stock valued at $5,949,000 after buying an additional 113,404 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its stake in NanoString Technologies by 27.1% during the second quarter. Point72 Asset Management L.P. now owns 274,612 shares of the biotechnology company’s stock valued at $8,334,000 after buying an additional 58,539 shares during the last quarter.
Several analysts have issued reports on the company. Zacks Investment Research lowered NanoString Technologies from a “hold” rating to a “sell” rating in a report on Friday, August 9th. BidaskClub lowered NanoString Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $24.60.
NanoString Technologies Company Profile
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
See Also: What is the Difference Between Common Shares and Convertible Shares?
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.